In addition, MPO-ANCA positivity is observed more frequently (ranging from 1.7% to 71%) in patients with ILD than PR3-ANCA positivity (0% to 29%) [14,23,27,33,34,35,36,37,38]. This evidence concerns the gene MPO and interstitial lung disease.